Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway

Hongyu Zhou1, Tao Shen2, Chaowei Shang2

  • 1State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China. Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA.

Oncotarget
|October 9, 2014
PubMed

Insights

Ciclopirox olamine (CPX) triggers autophagy in rhabdomyosarcoma cells via reactive oxygen species (ROS) and JNK signaling. Inhibiting autophagy enhances CPX

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Ciclopirox olamine (CPX), a known fungicide, shows potential as an anticancer agent.
  • The precise anticancer mechanisms of CPX remain largely unelucidated.
  • Understanding CPX's cellular effects is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the anticancer mechanism of CPX in human rhabdomyosarcoma cells.
  • To determine the role of autophagy and related signaling pathways in CPX's effects.
  • To explore novel therapeutic strategies combining CPX with autophagy inhibitors.

Main Methods:

  • Induction of autophagy by CPX in Rh30 and RD rhabdomyosarcoma cell lines.
  • Assessment of reactive oxygen species (ROS) production using N-acetyl-L-cysteine (NAC).
  • Analysis of mitogen-activated protein kinase (MAPK) pathway activation (ERK1/2, JNK, p38).
  • Pharmacological inhibition of JNK (SP600125) and autophagy (chloroquine, CQ).

Main Results:

  • CPX treatment induced autophagy in human rhabdomyosarcoma cells.
  • CPX-induced autophagy was dependent on reactive oxygen species (ROS) generation.
  • ROS-mediated activation of the JNK signaling pathway contributed to CPX-induced autophagy.
  • Inhibition of autophagy by chloroquine (CQ) potentiated CPX-induced cell death.
  • CPX-induced autophagy plays a pro-survival role in these cancer cells.

Conclusions:

  • CPX induces autophagy in rhabdomyosarcoma cells through ROS and JNK signaling.
  • Autophagy acts as a pro-survival mechanism, limiting CPX's anticancer efficacy.
  • Combining CPX with autophagy inhibitors presents a promising strategy to enhance its therapeutic potential against rhabdomyosarcoma.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K